Allosteric Inhibition of Bcr-Abl Kinase by High Affinity Monobody Inhibitors Directed to the Src Homology 2 (SH2)-Kinase Interface* - Journal of Biological Chemistry
Structure, Regulation, Signaling, and Targeting of Abl Kinases in Cancer - Oliver Hantschel, 2012
BCR-ABL1 and the Philadelphia chromosome - Part 3: The BCR-ABL fusion protein - YouTube
Bcr-Abl tyrosine-kinase inhibitor - Wikipedia
Allosteric BCR-ABL inhibitors in Philadelphia chromosome-positive acute lymphoblastic leukemia: novel opportunities for drug combinations to overcome resistance | Haematologica
IJMS | Free Full-Text | Blockade of Y177 and Nuclear Translocation of Bcr- Abl Inhibits Proliferation and Promotes Apoptosis in Chronic Myeloid Leukemia Cells
Differential signaling networks of Bcr–Abl p210 and p190 kinases in leukemia cells defined by functional proteomics | Leukemia
STI571: an inhibitor of the BCR-ABL tyrosine kinase for the treatment of chronic myelogenous leukaemia - The Lancet Oncology
![PDF] Molecular Pathways Molecular Pathways : BCR-ABL | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/7afde5a58c37047c83cde7051c4024ff35912884/2-Figure1-1.png "PDF] Molecular Pathways Molecular Pathways : BCR-ABL | Semantic Scholar")
PDF] Molecular Pathways Molecular Pathways : BCR-ABL | Semantic Scholar
Bcr-Abl阻害 | Bcr-Abl Inhibition
shRNA Loss-of-Function Screen Identifies Alternate Pathway for BCR-ABL - Cellecta
Structure and Dynamic Regulation of Abl Kinases* - ScienceDirect
IJMS | Free Full-Text | The Role of Mitochondrial DNA Damage and Repair in the Resistance of BCR/ABL-Expressing Cells to Tyrosine Kinase Inhibitors
Role of the ABL tyrosine kinases in the epithelial–mesenchymal transition and the metastatic cascade | Cell Communication and Signaling | Full Text
Imatinib resistance in chronic myeloid leukaemia caused by Bcr-Abl kinase domain and non-Bcr-Abl mutations: a comparison and review. - Australian Medical Student Journal
Frontiers | The Discovery of Novel BCR-ABL Tyrosine Kinase Inhibitors Using a Pharmacophore Modeling and Virtual Screening Approach
A model for the regulation of BCR-ABL nuclear import through conformational interplay between the kinase domain, the FABD and the NLS region.
Schematic representation of the mechanism of action of the BCR-ABLTKIs.... | Download Scientific Diagram
Tyrosine-kinase inhibition in treatment of chronic myeloid leukaemia - The Lancet
JCI - Applying the discovery of the Philadelphia chromosome
Figure 1 from STI571: targeting BCR-ABL as therapy for CML. | Semantic Scholar
Mechanism of Action of BCR-ABL and of Its Inhibition by Imatinib. Panel... | Download Scientific Diagram
The tyrosine kinase c-Abl potentiates interferon-mediated antiviral immunity by STAT1 phosphorylation - ScienceDirect
